USPTO 2015–2025 USPTO PatentsView US Corporation

Resodyn Corporation

USPTO PatentsView assignee record - 15 granted patents across 9 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing).

RSS updates for this company

The verdict

According to USPTO PatentsView, Resodyn ranks #19,082 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 9 technology areas.

#19,082
of 49,997 US assignees by volume
48th percentile
by Innovation Score (34.5/100)
16.5
avg claims per patent
+0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19082 · US Corporation #19,082 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-MICRO 15 grants
  • MID-PACK #19,082/49,997
  • PHOTO-FINISH Redx Pharma
  • CPC-NARROW B01F · 9 areas
  • INNOV-THIN 34.5/100
  • CLAIMS-RICH 16.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-FLAT +0% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Redx Pharma PLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Resodyn’s 34.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Resodyn

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Resodyn's Innovation Score is 34.5/100 (48th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Resodyn?

Each dot is one of Resodyn’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Resodyn’s own 16.5 claims/patent is ABOVE the 12.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Resodyn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 510152025 Granted patents (volume) Avg claims / patent Redx Pharma PLC - 15, 19.4Redx PharmaRememdia LC - 15, 23.47Rememdia LCResMed Asia Pte. Ltd. - 15, 9.4Resmed Asia PteResearch & Design Innovations, LLC - 15, 12.6Research & Design…Rhein Chemie Rheinau GmbH - 15, 12.73Rhein Chemie Rhei…RhinoSystems, Inc. - 15, 11.6RhinosystemsRobern, Inc. - 15, 16.13RobernS&SX-ray Products, Inc. - 15, 12.13S&Sx-ray ProductsResodyn Corporation - 15, 16.53Resodyn
Resodyn vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Resodyn's grants concentrate

Resodyn Corporation is a focused PatentsView assignee: 9 CPC subclasses with 86.7% of grants classified under B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing). Peak complete grant year is 2019 (3 grants) versus a trough of 1 in 2020. By volume, Resodyn sits between Redx Pharma PLC and S&SX-ray Products, Inc..

Resodyn's three-year grant acceleration

Resodyn Corporation shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Resodyn's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Resodyn holds 15 patents at rank #19,093, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Resodyn

By rank, the assignees closest to #19,093 in granted patent volume.

Leaders in B01F (Mixing)

Other assignees with the most granted patents in Resodyn's primary technology class.

Resodyn's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 48th percentile higher than 48% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20172018201920202021202320242025 1
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Resodyn Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 2 13.3%
2018 2 13.3%
2019 3 20.0%
2020 1 6.7%
2021 2 13.3%
2023 3 20.0%
2024 1 6.7%
2025partial year 1 6.7%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Resodyn Corporation's patent record in context - here's where to go next.

  • Resodyn Corporation's lead technology class is B01F (Mixing, e.g. Dissolving, Emulsifying OR Dispersing), 86.7% of its portfolio - see every assignee active in that class. Explore B01F
  • Ranked #19,082 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Resodyn Corporation against Redx Pharma PLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 34.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.